From Name:
From Email:
To Name:
To Email:

Optional Message:

For treatment of polycythemia vera, FDA approves Jakafi, a targeted therapy

from Forbes

The FDA approved Jakafi, a pill, for use in treating polycythemia vera. The drug, a targeted kinase inhibitor manufactured by Incyte, offers a needed option for some people affected by this serious blood disorder, a type of myeloproliferative disease. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063